One sentence summary: This review highlights Klebsiella pneumoniae as a crucial pathogen in the burden of antibiotic resistance, encompassing multi and extremely drug resistant high-risk strains which cause worldwide infections. This poses the urgent need to identify new targeted strategies for prevention and treatment.
INTRODUCTION
After more than 70 years of extensive use of antibiotics to treat infectious diseases, antibiotic resistance is now being recognized as a worldwide crisis in modern medicine (The Review on Antimicrobial Resistance, O'Neill 2016) . The dramatic increase in prevalence of infections caused by multidrug-resistant (MDR) and extremely drug resistant (XDR) pathogens belonging to the Enterobacteriaceae group poses a great concern since these pathogens are common natural inhabitants of our microbiome. Moreover, infections caused by these strains are often associated with high mortality rates, prolonged hospitalization and costs (Giske et al. 2008) .
Antibiotic resistance is a multifactorial complex process (Watkins and Bonomo 2016) . However, from the bacterial perspective it reflects evolution in action, concomitant to the continuous exposure to antibiotics, where selective pressure gives rise to the evolvement of multiple genetic mechanisms (Davies and Davies 2010 ). This constant evolution over the years has led to the emergence of MDR and XDR Enterobacteriaceae strains (Magiorakos et al. 2012 ) that exhibit resistance to nearly all antibiotics available, without possible treatment options (Hersh et al. 2012) . The risk of global dissemination of these XDR pathogens has become a recognized global threat.
In the context of antibiotic resistance, a 'successful' bacterial strain should be an extremely effective vehicle for the dissemination of antibiotic resistance traits. This can be accomplished if it can transfer its antibiotic resistance traits vertically to its daughter cells, and also if it can act as a donor for mobile genetic elements (MGEs), like plasmids and transposons, that may be transferred horizontally to other strains, species or genera (Woodford, Turton and Livermore 2011) .
In this era of antibiotic resistance, Klebsiella pneumoniae represents one of the most concerning pathogens involved in antibiotic resistance and as such, together with other highly important MDR pathogens, it has been classified as an ESKAPE organism (Boucher et al. 2009) .
Klebsiella pneumoniae, belonging to the Enterobacteriaceae family, is a natural inhabitant of the gastrointestinal tract microbiome of healthy human and animals. It is a common opportunistic hospital-associated pathogen, accounting for about one third of all Gram-negative infections overall. It is involved in extra-intestinal infections including urinary tract infections, cystitis, pneumoniae, surgical wound infections and life-threatening infections, such as endocarditis and septicemia. It is also an important cause of serious communityonset infections such as necrotizing pneumonia, pyogenic liver abscesses and endogenous endophthalmitis (Podschun and Ullmann 1998) .
Alongside with its high prevalence, K. pneumoniae is a major source for antibiotic resistance. Data retrieved from the European Antimicrobial Resistance Surveillance Network, (http://atlas.ecdc.europa.eu/public/index.aspx?Instance = GeneralAtlas) for the years 2005-2015, shows non-susceptible rates for K. pneumoniae and Escherichia coli, against the four major antibiotic classes: the third-generation cephalosporins, aminoglycosides, fluoroquinolones and carbapenems (Fig. 1) . It is noticeable that resistance rates in K. pneumoniae steadily increase over the years. Resistances vary considerably between countries; Eastern and South-Western Europe, as well as Mediterranean countries, are endemic to MDR K. pneumoniae, due to ESBL production, exceeding 50%-60% non-susceptibility for thirdgeneration cephalosporins, fluoroquinolones and aminoglycosides ( Fig. 1A-C) . As for carbapenems, while in 2005 almost all regions were free of carbapenem non-susceptible Klebsiella, in 2015 carbapenem-resistant K. pneumoniae (CRKP) has emerged in several countries, such as Romania, Italy and Greece, reaching non-susceptible rates of 40%-60% (Fig. 1D) . Interestingly, despite the variations observed between countries, the data show the superiority of K. pneumoniae, compared to E. coli, in non-susceptible rates to all classes of antibiotics, especially to carbapenems, the last resort β-lactams. The percentage of carbapenem non-susceptible K. pneumoniae is extremely high in endemic countries compared to carbapenem non-susceptible E. coli (Fig. 1D ). These differences in resistance rates between E. coli and K. pneumoniae are stable throughout the last decade, and highlight the major role of this later pathogen in the burden of antibiotic resistance.
The worldwide increase in occurrence of MDR and XDR K. pneumoniae reflects multifactorial dissemination processes that include (i) spread of High risk (HiR) global multiresistant genetic lineages (Woodford, Turton and Livermore 2011) ; (ii) acquisition of successful multiresistant plasmids and (iii) acquisition of resistance genes located on successful transposons.
In this review, we focus on the main features of K. pneumoniae that shape it as a highly important worldwide antibioticresistant pathogen. We provide an overview of all antibiotic resistance genes (ARGs) and mechanisms in this species, against the first and last line antibiotic treatments (Fig. 2) . Using a time-line presentation, we demonstrate that under a continuous antibiotic selective pressure the resistome evolves constantly, and may accumulate various ARGs in a specific K. pneumoniae genetic background leading to the evolution of MDR and XDR carbapenem-resistant clones. Alongside the resistome, we present characteristics of 52 fully sequenced antibiotic resistance plasmids of K. pneumoniae that enable the inter-and intraspecies transfer of resistance via horizontal transfer (Table 1 and Fig. 3 ). These self-transferrable plasmids are referred to as K. pneumoniae 'mobilome' and they encompass plasmids that harbor ARGs and transposons. These diverse resistome and mobilome of K. pneumoniae contribute to the evolution of the XDR phenotype in both epidemic and sporadic sequence types (STs) or clones. When these ARGs and plasmids become associated with strains that have high epidemic potential, the clones become HiR (Woodford, Turton and Livermore 2011) . We present the nine main epidemic K. pneumoniae clones associated with multinational outbreaks, and describe their ARGs repertoire and associated plasmids (Table 2) . We discuss the unique traits described in the literature that may be involved in their epidemic success compared to non-outbreak clones. We highlight the importance of these clones to serve as HiR bacterial hosts and shuttles for antibiotic resistance, and summarize their possible dissemination routes including patient-to-patient spread, silent colonization via human and animals reservoirs, and across countries via medical tourism (Fig. 4) .
KLEBSIELLA PNEUMONIAE RESISTOME
The resistome is defined as the collection of all the genes that confer antibiotic resistance (Wright 2007) . We searched PubMed for all genes (ARGs) and mechanisms that confer resistance to five important classes of antibiotics used to treat K. pneumoniae infections, including β-lactams, aminoglycosides, quinolones, tigecycline and polymyxins. We summarized the Klebsiella resistome encompassing all ARGs reported in this species over the years since the first use of β-lactam antibiotics in the 1940s. We also marked the chromosomal or plasmid location of these genes (Fig. 2) . European data on non-susceptible rates of E. coli and K. pneumoniae to antibiotics (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) . Data describing non-susceptible rates for E. coli and K. pneumoniae with respect to four classes of antibiotics, third-generation cephalosporins, aminoglycosides, fluoroquinolones and carbapenems. Percent non-susceptibility values were retrieved from the ECDC database http://atlas.ecdc.europa.eu/public/index.aspx?Instance=GeneralAtlas.
Since the emergence of ESBLs in K. pneumoniae, during the 1990-2000s, this pathogen has become the major ESBL-carrying pathogen associated in nosocomial outbreaks. In Israel and Spain, a prevalence of 40% of ESBL production among the total K. pneumoniae hospital isolates was reported (Navon-Venezia et al. 2003; Cantón et al. 2008) . During that period, K. pneumoniae strains harbored mainly TEM and SHV β-lactamases (Chong, Ito and Kamimura 2011) , with high occurrence and spread of various alleles in numerous countries ( Fig. 2; Livermore 2012 ). In the 2000s, there was a shift in the type of ESBLs present in K. pneumoniae, causing hospital outbreaks, due to acquisition of plasmids and transposons encoding bla CTX-M -type ESBLs, that led to the dominance of CTX-M-producing strains (Calbo and Garau 2015) .
Additional groups of ESBL genes were transferred to K. pneumoniae by horizontal gene transfer (HGT) including bla OXA -type ESBLs (Evans and Amyes 2014) , and the rare genes bla GES and bla SFO (Bradford 2001) , or bla PER , bla TLA and bla VEB (Philippon et al. 2016) . Moreover, inhibitor-resistant β-lactamase genes have emerged, encoding enzymes that are partially inhibited by clavulanic acid and tazobactam (Bush and Jacoby 2010) .
After 30 years since their emergence, the occurrence of ESBLproducing K. pneumonia is increasing worldwide, reaching an epidemic proportion in many countries (Fig. 1; Calbo and Garau 2015) , although prevalence and ESBL gene content varies between different geographical regions. According to World Health Organization (WHO), the occurrence of ESBL-producing K. pneumoniae has reached now endemic rates of up to 50% in many parts of the world, and up to 30% resistance rates in the community demonstrating the widespread nature of this resistance (Antimicrobial Resistance, Global Report on Surveillance. WHO 2014).
Plasmid-mediated AmpC genes
The remarkable versatility of K. pneumoniae to incorporate β-lactamase genes onto transferrable plasmids that enable their spread, gave rise to the emergence and spread of plasmid-mediated AmpC-like cephalosporins in this species (Jacoby 2009; Bush 2010) . These genes emerged during the late 1980s and early 1990s, in parallel with the explosion of ESBL genes, and they are entirely plasmid-borne in K. pneumoniae (Jacoby 2009 ). The most abundant bla AmpC gene families in this species belong to the CMY, DHA, FOX and MOX types, and their first years of occurrence in K. pneumoniae are shown in Fig. 2 . Plasmid-encoded bla ACT , bla MIR , bla ACC and bla LAT seem to be highly rare AmpC genes in K. pneumoniae, and were not added to the time line. However, evolutionary tendency to incorporate resistant genes onto the chromosome occurred, and the first chromosomal AmpC bla CMY-2 was identified in K. pneumoniae in 2009 (Fig. 2 , Zamorano et al. 2015) . Klebsiella pneumoniae strains showing enhanced resistance to β-lactams due to the existence of bla AmpC combined with porin loss, or increased efflux, were also reported as with the case of bla ACT-1 . These genes can also be easily overexpressed on plasmids due to multiple copies, or increased promoter strength of plasmid genes, and even lead to carbapenem resistance (Jacoby 2009 ).
Carbapenem resistome
The endemic occurrence of ESBL-producing K. pneumoniae in various parts of the globe was reflected by ongoing exponential evolvement of new ESBL-types and alleles within this species, as well as in other Enterobacteriaceae, acquired by horizontal transfer of ESBL-encoding plasmids and transposons. The MDR phenotype characteristics of these ESBL-producing K. pneumoniae strains have led to a significant increase in carbapenem use, which became the last resort antibiotics to treat ESBLproducing K. pneumoniae (Livermore and Woodford 2006) . The extensive use of carbapenems has resulted in the evolution of plasmid-mediated carbapenemases, i.e. enzymes that hydrolyze all β-lactams including the last-line carbapenems (Queenan and Bush 2007) . Their appearance in Enterobacteriaceae led to carbapenem-resistant Enterobacteriaceae (CREs). Probably due to its hospital association, Klebsiella turned out to be the major CRE to have spread worldwide (Cantón et al. 2012) , posing a significant public health threat (Chen et al. 2014c) .
Imipenem was the first carbapenem antibiotic used to treat K. pneumoniae infections back in 1983 (Baumgartner and Glauser 1983) , and imipenem-resistant strains were recognized already after 2 years (Knothe, Antal and Krcméry 1987) . The earliest detected carbapenemase was IMP-1 metallo-enzyme, detected in K. pneumoniae from 1991 in Japan (Haruta et al. 2000) . Several years later, in 1996, the first K. pneumoniae carbapenemase, named KPC, has emerged in the United States (Yigit et al. 2001) .
Although other carbapenemase genes occured in K. pneumoniae and were even reported in this species for the first time, such as bla (Poirel et al. 2004 ) and bla NDM-1 (Yong et al. 2009) , it is undoubtable that bla KPC became the most prevalent and highly impacting carbapenemase in K. pneumoniae. Strains carrying bla KPC have been described in all continents, with bla KPC-2 and bla KPC-3 being the most common genes, highly prevalent in strains involved in hospital outbreaks in many countries (Mathers, Peirano and Pitout 2015) . The main driving force for spread of these genes was and is still clonal expansion of K. pneumoniae ST258, which, since its first report in the United States (Kitchel et al. 2009 ), has become endemic in many parts of the world (Munoz-Price et al. 2013 ), as will be discussed further. Along with clonal dissemination, bla KPC genes reside in a unique Tn4401 transposon variants (Naas et al. 2012) , and are inserted into plasmids of various replicon types, which facilitates the dissemination of the gene to other bacterial species (Chmelnitsky et al. 2014 ). An interesting example of interspecies transfer of transposon-encoded bla KPC-3 gene from K. pneumoniae to E. coli was reported in a patient from the United States. A Serratia marcescens isolate carrying E. coli plasmid harboring this transposon was sequentially recovered from the same patient, demonstrating K. pneumoniae as a source for KPC genes in multiple pathogens (Sidjabat et al. 2009 ).
Along with their activity against all β-lactam antibiotics and high transferability, KPCs often possess resistance to common β-lactamase inhibitors, posing a clinical challenge (PappWallace et al. 2010) . Increased mortality was shown for infections caused by KPC-producing K. pneumoniae (Munoz-Price et al. 2013) .
With the increasing use of carbapenems to treat ESBLproducing K. pneumoniae infections, numerous processes occurred: (i) carbapenem resistance emerged without the actual carriage of a carbapenemase gene as a result of permeability alterations due to porin loss and overexpression of efflux pumps. The first description of this phenomenon was in 1988 ( Van de Klundert et al. 1988) , and was further demonstrated by a combination of high-level plasmid-mediated AmpC bla ACT-1 together with porin loss (Bradford et al. 1997) ; decreased susceptibility to ertapenem by a combination of ESBL and loss of OmpK36 (Martínez-Martínez 2008; Leavitt et al. 2009) , and the involvement of AcrAB efflux pump (Padilla et al. 2010) . (ii) The emergence of unique ESBL genes with wider spectrum of activity, such as bla GES (Queenan and Bush 2007) . The first GES-type carbapenemase acquired in K. pneumoniae was bla , identified in 2002 (Wachino et al. 2004) . These enzymes are relatively rare in K. pneumoniae, and were mostly reported from Greece, Finland, South Korea and Brazil (Lee et al. 2016) . (iii) New plasmidencoded carbapenemase genes like bla and bla VIM arrived in K. pneumoniae (Fig. 2) , now reported as endemic in different countries (Woodford, Turton and Livermore 2011) . (iv) Translocation of carbapenemase-encoding genes, such as bla VIM-1 and bla NDM-1 , from plasmids onto K. pneumoniae chromosome, by MGEs that were unique for these ARGs, making these resistances merely impossible to control ( Fig. 2 ; Lee et al. 2016) .
Multiple β-lactamase-encoding Klebsiella pneumoniae Carriage of multiple β-lactamase genes in the same strain is a known ability of K. pneumoniae and may contribute to the selective success of this pathogen. Combinations of all types of bla genes were reported in this species (Lee et al. 2016) . This may be due to either (i) carriage of an antibiotic-resistant plasmid encoding an array of ARGs due to acquisition of transposons containing different bla genes on the same plasmid or (ii) co-carriage of more than one antibiotic resistance plasmid. Individual strains may carry multiple bla genes like the description of a strain isolated from a sputum of a hospitalized patient in New York City, carrying up to 10 different bla genes including a FOX-like plasmid-mediated AmpC, bla KPC , bla SHV and inhibitorresistant β-lactamases (Moland et al. 2007) , or a strain carrying bla NDM-1 and bla OXA-232, on two different plasmids (Doi et al. 2014) .
The evolutionary advantage for K. pneumoniae to harbor multiple β-lactamases with an overlapping catalytic activity, is an understudied area. There are indications that multiplicity of β-lactamases may be involved in extra reliable resistance. For example, IMP, VIM and NDM carbapenemases are susceptible only to aztreonam among β-lactam antibiotics, but they usually hide that gap with the presence of ESBL or AmpC β-lactamase (Molton et al. 2013) . Extra copies of genes were also connected to higher resistance level (Chaves et al. 2001) , or bacterial response towards increased antibiotic concentration (Huang et al. 2013) . Further functional studies should be performed to elucidate the synergism of β-lactamases.
Aminoglycoside resistance genes
Aminoglycosides were actively used from mid-1940s to 1980s until they were replaced with third-generation cephalosporins, carbapenems and fluoroquinolones (Krause et al. 2016) . During that period of use, K. pneumoniae gained the main resistance mechanisms against this group, involving drug modification enzymes with different activities, such as acetylation, adenylation or phosphorylation (Benveniste and Davies 1973) . Within 10 years, plasmid-mediated resistance genes of all classes, aac, ant (grouped with aad), and aph gene families, were identified in K. pneumoniae (Fig. 2) .
Decrease in aminoglycoside usage slowed down evolution of new resistance mechanisms until the discovery of 16S rRNA methylase, belonging to the armA gene family, that encodes enzymes which prevent aminoglycosides to bind to their 16S rRNA target (Doi, Wachino and Arakawa 2016) . These genes are plasmid-encoded in K. pneumoniae (Galimand, Courvalin and Lambert 2003) , and while drug-modifying enzymes have a narrow spectrum of activity, 16S rRNA methylases confer resistance to practically all aminoglycosides, including plazomicin, the most recent aminoglycoside compound developed (Poulikakos and Falagas 2013) . Chromosomal location of armA was described in K. pneumoniae only once (Yu et al. 2009 ). Other known plasmidmediated 16S rRNA methylases including Rmt family and NpmA were also found in K. pneumoniae (Krause et al. 2016) , with no evidence of chromosomal location (Fig. 2) .
Chromosomal resistance mechanisms against aminoglycosides in K. pneumoniae include modifications in cell permeability due to alterations in AcrAB-TolC and KpnEF efflux pump systems, and due to loss of putative porin, KpnO. Disruptions in AcrAB-TolC increased susceptibility to tobramycin and gentamicin (Padilla et al. 2010) , whereas kpnEF mutant showed strong change in resistance to tobramycin and spectinomycin (Srinivasan and Rajamohan 2013) , but affected only slightly resistances to gentamicin and streptomycin. This may suggest different affinities of the permeability apparatus to different aminoglycosides. Direct involvement in aminoglycoside resistance was reported in vitro for KpnO porin, which upon loss caused resistances to tobramycin, streptomycin and spectinomycin ( Fig. 2 ; Srinivasan et al. 2012) .
Mutations which confer resistance via target modification, such rrs or rpsL, have not been found yet in clinical strains of K. pneumoniae. It is possible that rpsL mutations are connected with high fitness cost and reduced virulence, so they are less preferable. Multiple copies of rrs in K. pneumoniae chromosome may also complicate the development of resistance due to mutations in this gene (Beceiro, Tomás and Bou 2013; Tsai et al. 2014) .
Quinolone resistance genes
Quinolones target bacterial topoisomerases blocking bacterial DNA replication. These drugs have been used in clinical practice since the 1960s, but their use increased extensively after the introduction of the first fluoroquinolones in the 1980s, which has led to development of bacterial quinolone resistance mechanisms (Naeem et al. 2016) . Klebsiella pneumoniae resistome combines all the resistance mechanisms known for quinolone resistance in gram-negative bacteria (Redgrave et al. 2014) , including target-site gene mutations, increased production of MDR efflux pumps, modifying enzymes and/or target protection proteins.
Cases of Klebsiella treated with nalidixic acid, the first clinically approved quinolone (Ward-McQuaid, Jichlinski and Macis 1963) , and norfloxacin, the first fluoroquinolone used against K. pneumoniae (Guerra et al. 1983) , were accompanied by the first evidences of chromosomal resistances to nalidixic acid (Davis, Lilly and Lowbury 1969) and to norfloxacin (Rydberg, Larsson and Miörner 1994) (Fig. 2) . The first and major resistance mechanism is chromosomal mutations in the quinolone binding targets, DNA gyrase (gyrA-gyrB subunits) and topoisomerase IV (parC-parE subunits). Mutations in gyrA and parC in K. pneumoniae (Deguchi et al. 1997) were recognized earlier than mutations in gyrB (Nam et al. 2013) and parE (Guillard et al. 2015) , and are probably more common ( Fig. 2 ; Nam et al. 2013) .
Changes in K. pneumoniae cell permeability have been reported to be involved in quinolone resistance, similar to their role in β-lactam resistance. These included OmpK36 deficiency (Martínez-Martínez et al. 1996) , overexpression of acrAB, the multidrug efflux pump gene (Mazzariol et al. 2002) and unaltered production of kdeA (Ping et al. 2007) (Fig. 2) . In vitro transferring of these genes into sensitive E. coli increased. Another important pump in K. pneumoniae, OqxAB, assumed to originate from the K. pneumoniae chromosome, has now been recognized to be involved in plasmid-mediated quinolone resistance (PMQR), and to mobilize and spread among other bacteria (Wong, Chan and Chen 2015) . Efflux pump regulators were also reported to be involved in quinolone resistance in K. pneumoniae; the years in which the first resistance was identified are indicated, as well as the alteration in expression found in quinolone-resistant K. pneumoniae strains (Fig. 2) .
Another group of quinolone resistance genes include PMQR determinants, which occur in K. pneumoniae, as in other Enterobacteriaceae (Jacoby, Strahilevitz and Hooper 2014) . These genes encompass members of the qnr genes, which encode a family of proteins that physically protect DNA gyrase and topoisomerase IV from the inhibitory activity of quinolones. The first qnr gene was discovered on a plasmid of K. pneumoniae isolated in 1994 in the United States (Martínez-Martínez, Pascual and Jacoby 1998). There is no evidence of qnr genes on the K. pneumoniae chromosome, although these proteins are chromosomally encoded in other gram-negative bacteria including disease-causing species like Shewanella algae, Citrobacter spp., Stenotrophomonas maltophilia, Vibrionaceae and Serratia marcescens (Nordmann 2005; Ruiz et al. 2012) .
Another PMQR gene, aac(6 )-Ib-cr, is the single gene responsible for quinolone modification in K. pneumoniae. It deactivates narrow spectrum quinolones such as ciprofloxacin and norfloxacin, which carry the unsubstituted piperazinyl group, a substrate of this enzyme (Ruiz et al. 2012) . Initially, it was plasmid-encoded in K. pneumoniae, but was recently found on chromosome of this species ( Fig. 2 ; Ruiz et al. 2012) . Aminoglycoside resistance is often accompanied with co-resistance to β-lactams and fluoroquinolones; aac(6 )-Ib-cr conferred resistance to both aminoglycosides (tobramycin, amikacin and kanamycin) and fluoroquinolones (ciprofloxacin and norfloxacin) (Schultsz and Geerlings 2012) . PMQR gene qepA encodes an efflux pump protein , and it has yet to be recognized on K. pneumoniae chromosome. Mechanisms provided by expression of PMQR genes produce low or moderate levels of resistance to quinolones, but they create favorable conditions for appearance of chromosomal gene mutants (Fàbrega et al. 2009 ).
Interestingly, the presence of other resistance genes together with PMQR determinants provides cross-selection in spite of the antibiotic chosen for treatment. In Mexico, bla CTX-M-15 was found on K. pneumoniae plasmids with qnrB (Silva-Sánchez et al. 2013) . Cases of K. pneumoniae harboring bla CTX-M-15 and aac(6 )-Ibcr were reported from different world regions (Bado et al. 2016) , and was suggested to possess an improved fitness due to the presence of bla CTX-M-15 (Tóth et al. 2014) . Thus, epidemic K. pneumoniae clones possess different modes of quinolone resistance which can be evolutionary important. Isolates belonging to the epidemic clones, discussed later herein, such as K. pneumoniae ST11, ST15 and ST147, often possess two or three resistancecausing substitutions in GyrA and ParC together with carriage of the PMQR gene aac(6 )-Ib-cr (Tóth et al. 2014) . The presence of oqxAB and porin loss were described for K. pneumoniae ST258 (Mathers, Peirano and Pitout 2015) .
Polymyxin resistance genes
Polymyxin disrupts membrane integrity through displacement of cations (Ca +2 /Mg +2 ) in the outer membrane, by binding to the negatively charged lipopolysaccharides (LPS) and leading to cell lysis (Falagas and Kasiakou 2005) . The history of polymyxin resistance in K. pneumoniae is shorter compared to other classes of antibiotics, owing to restricted use in human medicine between 1980s and 2000s, due to recognized toxicity (Fig. 2) . The first clinical isolate of colistin-resistant K. aerogenes (now classified as pneumoniae) was isolated during the first period of usage (Davis, Lilly and Lowbury 1969) . In the early 2000s, with the increasing occurrence of XDR carbapenemase-producing K. pneumoniae (CPKP) strains, therapy often relied on polymyxins, which became one of the last line of drugs (Falagas and Kasiakou 2005; Antoniadou et al. 2007 ). The first hospital outbreak of colistin non-susceptible MDR K. pneumoniae was reported in 2004 from Greece (Antoniadou et al. 2007) , and since then an increasing number of reports on the recovery of colistin-resistant strains emerged from the clinical setting (Marchaim et al. 2011) . The major mechanism of polymyxin resistance in K. pneumoniae is target modification, achieved by chromosomal mechanisms, and is referred to as the 'LPS modification system'. Strains equipped with this multifaceted system alter the LPS structure, resulting in decreased anionic charge interfering with polymyxins binding. These changes in LPS are provided by mutations in several core genes, responsible for the maturation of lipid A (lpxM and its regulator ramA) (Clements et al. 2007; De Majumdar et al. 2015) and by neutralization of lipid A, by additional binding of amino arabinose (pbgP, pmrE), phosphoethanolamine (pmrC) or palmitate (pagP) (Mitrophanov et al. 2008; Llobet et al. 2011) . Resistance also involves increased activity of numerous LPS-modifying gene regulators, such as phoPQ, pmrA and pmrD (Fig. 2, highlighted) . Mutation in one of two other regulation genes, leading to pmrB overexpression (Jayol et al. 2014) or mrgB deactivation , is already sufficient to cause resistance to polymyxins. Another potential pathway for LPS modification involves TupA-like/glycosyltransferase and CrrAB regulatory system described by Wright et al. These numerous pathways that lead to colistin resistance in K. pneumoniae in the clinical setting are complexed, may derive independently in a specific strain genetic background and are less common via patient-to-patient spread of resistant strains (Wright et al. 2015) .
Additional mechanisms found to be involved in colistin resistance in K. pneumoniae are capsule polysaccharides (CPS) that may mask charged molecules on the outer membrane, and an increased expression of efflux pumps AcrAB-TolC and KpnEF (Srinivasan and Rajamohan 2013) , due to positive regulation of their transcription by RarA (De Majumdar et al. 2013) .
Plasmid-mediated polymyxin resistance was reported only recently, with the identification of the mcr-1 gene in China (Liu et al. 2016) . This gene encodes a phosphoethanolamine transferase enzyme family that modifies lipid A by connecting it with phosphoethanolamine, similarly to the activity of PmrC (Liu et al. 2016) . The mcr-1-encoding plasmid, although originally found in E. coli, was conjugated and expressed in vitro in K. pneumoniae. Shortly after, widespread occurrence of this gene was reported in various countries across the globe. It was suggested to originate from E. coli with chicken origin, presumably due to extensive colistin use in the poultry (Schwarz and Johnson 2016; Zhi et al. 2016) .
For CRKP, only tigecycline, colistin and some aminoglycosides still show favorable in vitro activities. Their XDR profile results in increased usage of colistin, which in turn leads to emergence of strains with induced resistance. This was demonstrated by widespread of colistin-resistance among KPCproducing K. pneumoniae (Lee et al. 2016) . Colistin-resistant K. pneumoniae was found to be significantly higher in prevalence as compared to other Enterobacteriaceae species. In a recent global surveillance program, Bradford et al. (2016) reported that although resistance rates to colistin, among carbapenemproducing bacteria, were 12%, K. pneumoniae comprised 95% of all these isolates.
Co-selection of colistin resistance was observed also as a result of a broad-spectrum cephalosporin treatment in ESBLproducing K. pneumoniae, when resistance to colistin was achieved due to disruption of mgrB by ISEcp1-bla CTX-M-15 (Jayol et al. 2016) or ISEcp1-bla OXA-181 (Zowawi et al. 2015) . High rates of colistin resistance (up to 36%) were found in carbapenemresistant K. pneumoniae in endemic areas like Italy linked to higher mortality (Capone et al. 2013) . Description of CRKP isolates carrying mcr-1 has just been started, but spread of this gene is already considered to be a serious threat resulting in strains that are pan-resistant (Karaiskos et al. 2016) .
Tigecycline resistance genes
Tigecycline is the first glycylcycline launched (Livermore 2005) , and it has been in use against K. pneumoniae infections from 2005, after it was shown to escape from the main resistance mechanisms known against tetracyclines (Schedlbauer et al. 2015) . Tigecycline was considered a promising drug, with a broad-spectrum activity even against ESBL-producing strains (Golan 2015) . Shortly after its first use, an MDR K. pneumoniae strain possessing decreased tigecycline susceptibility (MIC 4 μg/mL) was isolated at a hospital (Fig. 2 , Ruzin et al. 2005) . According to the currently recommended tigecycline breakpoints, this strain was actually intermediately resistant to tigecycline (Osei Sekyere et al. 2016) ; however, since that report, tigecycline resistance among K. pneumoniae isolates has been increasingly reported. Known resistance mechanisms against this antibiotic are chromosomally encoded, and include modifications of both the 30S and the 16S ribosomal unit targets of the antibiotic, as well as changes in cell permeability (Osei Sekyere et al. 2016) . Overexpression of the efflux pumps AcrAB-TolC and OqxAB and alterations in the expression levels of their regulators RarA, RamA, RamR and AcrR were also shown to contribute to resistance (Fig. 2; Osei Sekyere et al. 2016) ; however, their role in resistance is not definitive, and may be due to the increased expression of other pumps, such as KpgABC, a putative novel pump, that was offered as an alternative mechanism of tigecycline resistance (Nielsen et al. 2014 ). Resistance was also higher in K. pneumoniae strains with decreased transcription of porin gene, ompK35 (Källman et al. 2008) . The first mutation in ribosomal protein leading to susceptibility decrease was noticed in protein S10, encoded by rpsJ (Villa et al. 2014) . tetA genes encoding efflux pump against tetracyclines were registered in tigecycline non-susceptible K. pneumoniae isolates, but their contribution to tigecycline resistance in this species is still unclear (Ahn et al. 2016) .
XDR resistome
The emergence of multiple resistances towards different antibiotic groups is frequently found in hospital-adapted K. pneumoniae isolates due to the accumulation of arrays of ARGs that may be encoded on multiple plasmids forming a 'super resistome'. A super resistome may encompass combinations of ESBLs and/or carbapenemase genes with aminoglycoside modifying enzymes, or association of CTX-Ms or NDM carbapenemases with 16S rRNA methylases as described in a recent review (Krause et al. 2016) . IncA/C plasmids, for example, encode NDM carbapenemase together with rmt methylases, quinolone resistance gene qnrA and AmpC-β-lactamase bla CMY (Pitout, Nordmann and Poirel 2015) . Another interesting example of a K. pneumoniae strain possessing a super resistome was shown carrying four different β-lactamases (bla NDM-1 , bla , qnrA and armA on one plasmid and bla and bla CTX-M-15 , each on separate plasmids), together with porin deficiency, quinolone resistance chromosomal mutations and additional ARGs (Seiffert et al. 2014) .
These super strains may be practically resistant to all available classes of antibiotics, posing a great challenge to clinicians due to limited available treatment options (Munoz-Price et al. 2013; Nordmann and Poirel 2014) , and are highlighted further in this review.
PLASMIDS ENCODING ANTIBIOTIC RESISTANCE IN KLEBSIELLA PNEUMONIAE
Antimicrobial resistance in K. pneumoniae has been attributed largely to the acquisition of large, self-conjugating plasmids. These extrachromosomal DNA molecules that encode factors promoting the initiation of replication, independently from the replication of the bacterial chromosome, maintain a constant copy number per bacterial cell and regulate their own replication rate (Nordström 2006) . The minimal portion of a plasmid that controls the initiation of replication, maintaining the copy number of the parent plasmid, is called the basic replicon (Kollek, Oertel and Goebel 1980) . In early studies performing bacterial typing of the emergent K. pneumoniae ST258 clone, plasmid replicon type was not determined, because most K. pneumoniae plasmids were not typable by the standard PCR-based replicon typing method (Carattoli et al. 2005) . Thanks to genomics, the complete sequencing of Klebsiella plasmids was recently obtained, demonstrating that K. pneumoniae was endowed with new set of plasmids, carrying new replicons that were not previously described. However, most of these novel plasmid types were related to the so called IncF plasmid family. IncF plasmids have been described in all species of Enterobacteriaceae, often associated with virulence genes. IncF-related plasmids are in the range of 60-200 kb in size, of low copy number and carry FII-related replicons. The typical FII replicon is constituted by the repA gene whose transcription is controlled by antisense RNAs, acting in trans via sequence complementarity on target sense mRNAs (Blomberg et al. 1994; Nordström 2006) . DNA sequences of FII replicons of plasmids from different species diverge, but may originate from a common ancestral replicon, showing overall >75% nucleotide identity. FII replicons characterize the large heterogeneous IncFII plasmid family, and can be subcategorized, based on PCR and sequencing, to the FII (Escherichia coli), FIIs (Salmonella), FIIy (Yersinia) and FIIk (Klebsiella) specific groups (Villa et al. 2010) .
The IncFIIk plasmids
A total of 306 DNA sequences are currently available at the NCBI nucleotide database, corresponding to no redundant, complete sequences of plasmids, identified in K. pneumoniae (http://www.ncbi.nlm.nih.gov/nuccore/, December 2016). The majority of these DNA sequences were generated by highthroughput sequencing of entire genomes. Among them 27 are small (<15 kb) and 279 large plasmids. We identified the replicons on these plasmids using the PlasmidFinder database (https://cge.cbs.dtu.dk/services/PlasmidFinder/) (Carattoli et al. 2014) . The most frequent replicon identified in this collection of in silico plasmids was the FIIk replicon (149/279 large plasmids, 53%). The FIIk was often found to be associated with replicons of the FIB-type (112/149 FIIk positives). The 'multireplicon' status allows the generation of plasmids that can replicate using alternate replicons, bypassing the incompatibility effect due to the simultaneous presence of two incompatible plasmids co-residing within the same cell (Osborn et al. 2000) .
Two types of FIB replicons have been found more frequently in K. pneumoniae plasmids, named FIB pKPQIL (48/149 FIIK positives) and FIB pKPN (63/149 FIIK positives). These two FIB replicons distinguished plasmids pKPQIL and pKPN3, respectively (Fig. 3) . These two plasmids are commonly found in fully sequenced K. pneumoniae genomes of the epidemic clonal group, CG258. Plasmids pKpQIL and pKPN3 very often co-reside within the same cell, show very similar transfer loci and FIIK replicons, and differ from the variable and the FIB-replicon regions (Fig. 3) .
Plasmid pKPN3, initially identified in the genome of K. pneumoniae ST258 clone isolated from Israel and USA (Leavitt et al. 2010) , encoded resistance to arsenic, copper and silver, by the ars, cus and sil loci, respectively (Fig. 3) . In several pKPN3 variants, the catA1, mphA, dfrA and aadA genes, conferring chloramphenicol, macrolides, trimethoprim and streptomycin resistance, respectively, were also found. The most peculiar feature of pKPN3 derivatives is the presence of various virulence factors, such as the lac operon cluster, encoding a transcriptional regulator (LacI), β-galactosidase (LacZ) and lactose permease (LacY), that differ from the chromosomally encoded lactose operon, the Fec-like iron(III) dicitrate transport system and a glutathione ABC transport system (García-Fernández et al. 2012 ).
An interesting variant of pKPN3 is represented by the pKPN-CZ plasmid identified in a K. pneumoniae ST416, from the Czech Republic (Dolejska et al. 2013 ). This bla CTX-M-15 -encoding plasmid carried mrkABCDF gene cluster, showing >99% nucleotide identity with the mrk cluster encoding a type 3 fimbriae, identified in K. pneumoniae chromosome. The same cluster was previously identified on IncX plasmids from E. coli, and this genetic trait was demonstrated to profoundly enhance the ability of E. coli to form biofilm (Ong et al. 2009 ). The pKPN-CZ also encoded a thermo-resistance cluster, deriving from the mobilization of a similar cluster from the chromosome of Cronobacter sakazakii strain ATTC29544 (92% coverage, 99% nucleotide identity; Acc. No. FR714908). The presence of these highly peculiar plasmid-mediated virulence traits assigns to pKPN3 and its derivatives, the role of Klebsiella specific virulence plasmids. These plasmids are very rarely reported in other enterobacterial species, presumably due to the narrow host range characteristic to IncFIIk plasmids that limits their dissemination to other species. The presence of these plasmids in K. pneumoniae, and their role in iron scavenging and biofilm formation, may contribute to Klebsiella persistence and survival within the hospital environment and in the human patient. Indications on the existence of pKPN3-derived plasmids exterritorial to a clinical setting were reported recently from a K. pneumoniae strain isolated from municipal wastewater treatment facilities in Israel that harbored a plasmid named pKPSH-11XI, encoding the quinolone resistance qnrB gene. These findings demonstrate the presence of these plasmids in the environment, suggesting the environment as a possible reservoir for antibiotic-resistant MGEs with significant clinical impact (Kaplan et al. 2015) .
Plasmids associated with carbapenemase genes bla KPC -encoding plasmids A retrospective study on K. pneumoniae isolates belonging to the epidemic ST258 clone carrying bla KPC , isolated in early 2000s in the USA, demonstrated that both bla KPC-2 and bla KPC-3 genes were encoded on IncFIIk pKpQIL plasmids, which were identical to the first completely sequenced pKpQIL of ST258 from Israel (Fig. 3 , Leavitt et al. 2010; Chen et al. 2014a) . Since the mid-2000s, this plasmid was recognized in ST258 isolates from around the world, proving its epidemic nature. The most common resistance traits of pKpQIL plasmid are as follows: bla KPC-3 located in the Tn440a transposon, mer operon, conferring resistance to mercuric ions, and the Tn3 transposon, carrying the bla TEM-1 gene (Fig. 3) . The smallest bla KPC-3 -encoding pKpQIL derivative reported to date is pSLMT, identified in K. pneumoniae from the UK (HQ589358). This plasmid constituted only the portion of pKpQIL backbone consisting of the FIIk replicon and the bla KPC-3 :Tn4401a transposon. This configuration suggests the possible origin of multireplicon pKpQIL structure that resulted from a fusion between the minimal portion of pKpQIL together with another episome, carrying the FIB pKpQIL , the transfer locus and other resistance determinants, generating the complete, frequently reported plasmid (Fig. 3) .
There are also mosaic bla KPC -encoding plasmids that seem to derive from IS26-mediated recombination between pKPN and pKpQIL, such as those generating pKPN3 derivatives carrying the bla KPC-2 identified in K. pneumoniae from the USA (Chen et al. 2013b) . It is reasonable to assume that the coexistence of more than one IncFIIk plasmid within the same K. pneumoniae cell may cause frequent rearrangements among these plasmids, by recombination among homologous regions, represented by the FIIk replicons, the transfer loci and the numerous IS26 elements scattered along the variable multidrug resistance regions.
Beside the IncFIIk, bla KPC-2 and bla KPC-3 were also identified on a wide variety of plasmids, including the IncN, IncX3, IncR, IncHI1 and IncI2 types (Table 1) . Tn4401b carrying the bla KPC-3 on IncI2 has been extensively reported in the USA and UK. Interestingly, an association between the different Inc groups carrying bla KPC-3 and K. pneumoniae CG258 strain clades has been noted; IncI2 plasmids were found only in clade II, while pKpQIL were found in both clades I and II (Chen et al. 2013a; Chen et al. 2014c , Deleo et al. 2014 .
IncR, IncN and IncX3 plasmids show broad host range and are often responsible for the horizontal transmission of bla KPC by conjugation to other Enterobacteriaceae. Two tandem copies of the Tn3-like element Tn4401a-bla KPC-3 were identified on an IncX3 variant in K. pneumoniae ST512, with duplication due to the intramolecular transposition of the Tn4401a transposon within the IncX3 scaffold (Fig. 3) . The plasmid conferred significantly increased MICs for carbapenems, cephalosporins and β-lactam/β-lactamase inhibitor combinations, compared to isogenic recipients carrying one copy of the Tn4401a-bla KPC-3 on pKpQIL. The MIC difference may be due not only to the double copy of the bla KPC and their level of gene expression, but also to IncX3 and pKpQIL different copy numbers. On the same IncX3 plasmid, the bla SHV-11 was identified 4 Kb apart from the Tn4401a-bla KPC-3 integration site, followed by an IS26 element. The same structure carrying IS26-bla SHV-11 -IS3000 was previously detected on plasmid pIncX3-SHV, co-resident with pKpQIL carrying bla in ST258 strains (Fig. 3) . It is therefore highly plausible that Tn4401a-bla KPC-3 transposed from pKpQIL into the pIncX3-SHV plasmid and the pKpQIL was then lost from the K. pneumoniae strain (Fortini et al. 2016) .
Other plasmid rearrangements have been noted to involve portions of IncFIIk plasmids fused in a multireplicon status with IncR or IncN plasmids. These fusions had a significant evolutionary success. For instance, FIIK-R multireplicon plasmids carrying bla KPC-2 have been identified in Italy, USA, China, Russia and Taiwan, suggesting a successful international spread of these plasmids (Table 1 ; Frasson et al. 2012 ).
Other carbapenemase-encoding plasmids VIM, IMP, NDM metallo-β-lactamases (MBL), GES and the carbapenem-hydrolyzing class D OXA β-lactamases (CHDL) have been described to be encoded on diverse plasmid types (Table 1) , of which some types emerged and spread in unrelated, geographically distant K. pneumoniae strains.
In Greece, epidemic IncN1 bla VIM-1 -carrying plasmids were identified in unrelated Klebsiella strains from different hospitals. These plasmids encoded a variable region consisting of multiple integrons and transposons (Miriagou et al. 2010) . Similar IncN1 plasmids were also described carrying the bla IMP4 -integron borne gene cassette (Lo et al. 2013) .
The bla NDM-1 gene in K. pneumoniae was mostly acquired by broad host range IncA/C2, IncHI1, IncX3 and IncN2 plasmids ( Table 1) . The IncA/C2 group is particularly important since it carries multiple determinants, conferring resistance to aminoglycosides (encoded by armA or rmtB 16S RNA methylases), chloramphenicol, trimethoprim and sulphonamides, together with the AmpC β-lactamase CMY-2 . They show a very broad host range, being able to replicate in Enterobacteriaceae, but also in Pseudomonas. However, bla NDM-1 in K. pneumoniae also emerged on plasmids that were not previously identified in other Enterobacteriaceae. For example, it was identified on pKpQIL derivatives in Asia and America, but also on novel plasmids. Among them, the most innovative was represented by plasmid pNDM-MAR first identified in Morocco, but also detected in isolates from the USA and UK. Belonging to a novel group within the IncHI family, pNDM-MAR diverged from the previously described IncHI1 and IncHI2 groups. This plasmid was endowed by the HIB-M and FIB-M novel replicons and bla NDM-1 , as well as being characterized by the presence of the ESBL bla CTX-M-15 , and qnrB1, aac6-1B, bla OXA-1 , catB3, telluric and mercuric ions resistance genes ( Fig. 3; Villa et al. 2012) . The bla NDM-5 associated with the plasmid-mediated colistin resistance gene mcr-1, and bla NDM-7 and bla OXA-181 carbapenemase gene variants were identified on IncX3 plasmids, suggesting that this plasmid type is highly frequent in K. pneumoniae (Table 1 ). The CHDL OXA-48 was identified in different K. pneumoniae STs (Table 2 ), but is always associated with the IncL plasmid, which is a highly conserved plasmid with epidemic occurrence in all continents (Poirel, Bonnin and Nordmann 2012) . In contrast, bla IMP-8 and bla GES-5 genes were detected on novel plasmid types (Papagiannitsis et al. 2015) .
Plasmids carrying ESBLs
ST11 and ST147 are HiR multiresistant K. pneumoniae clones, producing CTX-M-15 or CTX-M-14, that have spread globally (Table 2 ; D' Andrea et al. 2013) . Plasmid typing performed on various collections of Klebsiella isolates demonstrated that bla CTX-M genes were mostly located on IncFII plasmids that differ from those carrying bla KPC, and are rather highly similar to the IncFII of E. coli. However, despite the probable common origin, these plasmids in Klebsiella diverged. For example, pKF3-70 carrying the bla CTX-M-14 gene from China had a conserved FII backbone but acquired an iron transport system, and several open reading frames of unknown function (Yi et al. 2010) . Plasmid pKP12226 encoding bla CTX-M-15 in K. pneumoniae ST11 identified from South Korea was a fusion of an IncFII plasmid carrying also the FIA replicon and the phage P1, which is capable of extrachromosomal replication by the IncY replicon (Shin and Ko 2015) .
Several reports identified CTX-M-15 and CTX-M-1-producing K. pneumoniae in companion animals, associated with plasmids that were commonly reported in E. coli from animal reservoirs, such as the IncI1, IncR and IncN plasmids Donati et al. 2014) . These evidences suggested that there was frequent horizontal exchange of ESBL-encoding plasmids among Klebsiella and other Enterobacteriaceae.
Interestingly, Klebsiella-specific bla CTX-M-15 -encoding plasmids were also recognized in K. pneumoniae ST416 clinical isolates from Czech Republic and Taiwan; pKDO1 (GenBank Acc. No. JX424423), pKF3-94 (FJ876826) and pK245 (NC˙010886) showed 52%-61% coverage, 84%-100% nucleotide identity with plasmid pKpQIL. Plasmid pKDO1 (Table 1, #37) carried the FII K7 replicon allele, associated with a novel and rare replicon encoding a Rep3 replicase. The plasmid pKDO1 contained a resistance region of 39760 bp, carrying qnrB1 and the bla CTX-M-15 gene. In addition, pKDO1 plasmid harbored the EcoRII restriction/antirestriction system flanked by an In4-type class 1 integron with the dfrA14 gene cassette, in a configuration previously described for some IncN plasmids (Dolejska et al. 2013) .
The bla CTX-M-3 gene is disseminated among Enterobacteriaceae in Europe on pCTX-M-3, a conjugative plasmid of the IncM family, carrying the armA 16S RNA methylases (Go lebiewski et al. 2007) . Plasmid pCTX-M-360, identified in K. pneumoniae in China, was highly related to the pCTX-M-3 plasmid, but lacked the region encoding ArmA, and had acquired multiple open reading frames encoding unknown functions (Zhu et al. 2009 ). Plasmids that are schematically presented in Fig. 3 are marked in bold.
Plasmids designated with an asterisk are considered as epidemic plasmids.
Overall, taking into account the species-specific IncFIIk plasmids, the diverging IncHI, IncI2 and IncN2 plasmids, together with the completely new replicons identified in this species, K. pneumoniae resistance plasmids are very often unique and different from those described in other Enterobacteriaceae.
Interspecies spread of Klebsiella carbapenem-encoding plasmids
Transfer of Klebsiella plasmids to other species in vitro was described frequently in the literature, mostly to E. coli, demonstrating the conjugation ability of these plasmids, and their potential to operate as shuttles for antibiotic resistance. Klebsiella serves as a worldwide source for carbapenem resistance by dissemination of its plasmids facilitated by HGT to other species. Spread of these ESBL and carbapenemase-encoding plasmids poses a major threat as acquisition of these plasmids turns bacteria to MDR or XDR.
Originating from Klebsiella in the USA (Smith Moland 2003), bla KPC-2 has been shown to cause interspecies spreading to other Enterobacteriaceae, including Salmonella (Miriagou et al. 2003) , Enterobacter sp. (Hossain et al. 2004 ), E. coli (Bratu et al. 2007) and Proteus mirabilis (Tibbetts et al. 2008) . Further intercontinental dissemination of bla KPC-2 in various Enterobacteriaceae was reported in distant parts of the world, including Enterobacter and E. coli from Israel (Navon- Venezia et al. 2006; Marchaim et al. 2011) , in the same species from Europe (Petrella et al. 2008) , and in Serratia marcescens and Citrobacter freundii from Asia (Zhang et al. 2007; Cai et al. 2008; Zhang et al. 2008) . Once bla KPC-2 is introduced in a certain location, especially in a hospital set-up, under antibiotic pressure, further dissemination of the gene may occur, as has been described in multiple clones of E. coli isolated during 2005-2008 in a tertiary hospital (Goren et al. 2010b) . Dissemination of bla KPC-2 into other gram-negative non-fermenters pathogens was reported in Pseudomonas aeruginosa from South America (Villegas et al. 2007; Akpaka et al. 2009 ) and the USA (Poirel et al. 2010) , in P. putida (Bennett et al. 2009 ) and in Acinetobacter baumannii (Robledo et al. 2010) .
Transfer of Klebsiella plasmids was reported into clinically important strains, such as the worldwide epidemic E. coli ST131 clone (Nicolas-Chanoine et al. 2008) . This ESBL-producing clone is a cause for multiple infections including bacteremia. Emergence of resistance to carbapenems in this clone by acquisition of bla KPC -encoding IncFIIk plasmid with a scaffold similar to that of pKpQIL was reported in the USA , and resulted in a XDR hypervirulent strain.
Transfer of KPC from K. pneumoniae to a commensal E. coli strain in a patient gut was demonstrated by the in situ acquisition of bla KPC-3 -encoding pKpQIL plasmid from a CRKP ST258 strain colonizing the patient gut, leading to the emergence of a carbapenem-resistant E. coli strain (Goren et al. 2010a ).
HIGH-RISK EPIDEMIC KLEBSIELLA PNEUMONIAE CLONES
The two main dissemination modes of an antibiotic-resistant pathogen in general and specifically K. pneumoniae are (i) clonal expansion of an antibiotic-resistant clone and (ii) HGT of antibiotic resistance elements from a resistant strain to a susceptible bacterium that turns resistant upon acquisition of the resistant element/s. Although both modes of spread act simultaneously throughout evolution, the main driving force for spread of K. pneumoniae over the years is the successful expansion of certain high-risk clones. The origin of a HiR clone in a certain vicinity can be either as a result of a local transmission of a specific clone or due to the import of a new clone from an endemic area.
The importance of HiR bacterial clones in the context of international dissemination of antibiotic resistance was first recognized by Woodford et al. The authors defined a 'high-risk clone' as isolates that belong to the same ST according to the multilocus sequence type (MLST) scheme, although isolates may have been isolated in a different geographic location, and time. Moreover, certain K. pneumoniae STs are considered more probable outbreak-causing agents as compared to others (Woodford, Turton and Livermore 2011; Chmelnitsky et al. 2013) . These are the clones that should be identified, monitored and controlled.
High-risk XDR worldwide Klebsiella pneumoniae clones
The number of outbreaks caused by a bacterial clone represents its epidemic potential. We searched PubMed using the keywords (K. pneumoniae, outbreak/epidemic/pandemic/ST), and focused on papers published after 2005, when K. pneumoniae MLST scheme was established (Diancourt et al. 2005) . Outbreaks of ESBL-producing K. pneumoniae, occurring prior to 2005, are well described elsewhere (Calbo and Garau 2015) . The inclusion criteria for 'a HiR K. pneumoniae clone' were a clone that caused at least four recognized outbreaks and that was reported from ≥10 countries. All nine ST clones identified were known CPKP.
The following STs, ST16, ST20, ST48, ST307, and ST340, ST336 and ST395, although recognized as important international outbreaks clones, were excluded from our analysis because at the time of this review they did not fulfill our inclusion criteria. It is important to emphasize that these clones are continuously disseminating and may become HiR in the future. Table 2 represents the distribution of bla gene alleles with highest enzymatic capacity within each HiR clone based on all reports connected to each ST including outbreaks, sporadic cases and surveillance reports. All HiR clones carry a diverse arsenal of bla genes including diverse carbapenemases and/or ESBLs (Table 2) . Certain STs harbor a main bla carbapenemase gene such as ST258 and ST512 that are linked to bla KPC , whereas isolates belonging to other STs may carry various carbapenemases. For example, ST15 is mostly a CTX-M-15 producer but also encodes all types of carbapenemases genes: bla KPC , bla OXA-48-like, bla NDM , bla VIM and bla IMP . This high variation of resistant genes within and between the clones reflects HGT of circulating ESBL-and carbapenemase-encoding plasmids and transposons, which may depend on bla genes and allele distribution in bacterial population in different geographic locales.
Clonal group 258
Since the first emergence of CRKP, nearly 100 international outbreaks caused by high-risk clones were reported in the literature ( Table 2 ). The most significant outbreak causing clonal group was CG258, responsible for 68% of all outbreaks and consisting of three STs: ST258, ST11 and ST512. The second most prevalent CG, responsible for ∼20% of all outbreaks was CG15, consisting of ST14 and ST15. The remaining CG are epidemic but to a lower extent (Table 2) .
CG258 is an intriguing clonal group due to its high spread and success. ST258, the most widespread clone of this CG, has emerged clinically in 2000. This hybrid clone emerged after recombination events between two K. pneumoniae clones. ST11 and ST442, and now is divided into two clades based on capsule type (Deleo et al. 2014 ). ST512 originated from ST258 clade II Table 2 . High-risk XDR K. pneumoniae clones causing worldwide outbreaks in humans (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) .
a Determined by MLST scheme. b The relative occurrence of each bla allele was determined by dividing the number of studies in which the indicated bla gene was reported in K. pneumoniae with the total number of studies retrieved from the search in PubMed for a specific ST (updated to October 2016). Each study was valued as one point. In the case of CPKP, only carbapenemases were taken into account. In presence of ESBLs or AmpC enzymes, penicillinases were neglected. When several bla genes were indicated in the same report, the one point was divided equally between all bla genes, i.e. if a strain carried blaOXA-48 and blaNDM-1, each allele gained relative occurrence of 0.5. c Plasmid types encoding bla genes only from reports described as outbreaks. d Number of reports retrieved from PubMed using a search for the indicated K. pneumoniae ST. Number of countries where K. pneumoniae STXX was reported in (islands were considered as independent countries). e L/M presently can be identified independently.
ND, not determined. via a single locus variation (Chen et al. 2014c; Bowers et al. 2015) , harbors mostly bla . The majority of CG258 members are XDR due to their multiple ARGs. There are isolates of CG258 that show ompK35 and ompK36 porin alterations (Bowers et al. 2015) as well as mutated mgrB causing colistin resistance (Cannatelli et al. 2014) . Comprehending the unique features of this epidemic CG and each of these epidemic STs will contribute to understanding their success, and will assist in designing improved diagnostic and prevention of their spread.
Linkage between KPC genes and successful clonal lineages Whole genome sequencing (WGS) and molecular epidemiology data reveal that global dissemination of ST258 occurred after it had acquired bla KPC -encoding plasmid. ST258 was reported with bla KPC genes in more than >90% of all cases. Outbreaks associated with this clone were KPC carrying, mainly bla KPC-3 and bla KPC-2 . A tight connection was shown between this clone, bla KPC /Tn4401 and plasmids pKPN3 and pKpQIL (Table 2 ; Bowers et al. 2015) . The remaining outbreaks are due to rare-VIM-producing isolates or non-producing carbapenemase derivatives, which are relatively rare. ST512 isolates are exclusively linked to bla KPC (Table 2) .
Interestingly, carbapenem-resistant bla KPC -negative variants of ST258, described from Israel, lacking pKpQIL, were bla CTX-M positive and ompK35 deficient, and disappeared from the clinical setting two and half years since their recognition, reflecting their inferior fit to the hospital environment (Adler et al. 2012) . It is speculated that acquisition of IncF plasmids significantly contributed to the evolutionary success not only of K. pneumoniae ST258, but also of E. coli ST131, a well-known pandemic Enterobacteriaceae clone (Mathers, Peirano and Pitout 2015) . This suggests that K. pneumoniae STs linked to a specific IncF plasmid may possess an advantage over clones that may carry diverse plasmids.
Superiority of CG258
Antibiotic resistance is an important advantage among pathogens in clinical settings, but it is not unique for HiR clones. Several reports point out numerous superior features of CG258 that may be related to its worldwide success. Genomic comparison study revealed the presence of 50 unique genes present in ST258 clone and absent in a non-ST258 sporadic clone (ST376) found to be related to cell motility, secretion and DNA repair and modification (Chmelnitsky et al. 2013) . Another study described the integrative conjugative element, ICEKp258.1, carried by ST258 and ST11, encoding a type IV secretion system, that possibly facilitates mobile elements propagation (Chen et al. 2014b) . Another element, ICEKp258.2, found in ST258 and in its offspring ST512, encodes a type IV pilus gene cluster, and a type III restriction-modification system, which may improve adherence abilities and narrow range of compatible plasmids and other mobile elements, respectively (Pitout, Nordmann and Poirel 2015) . This may explain the low diversity of bla carbapenemases in ST258 and ST512 compared to ST11 (Table 2 ). In addition to antibiotic resistance, K. pneumoniae ST258 showed reduced susceptibility to chlorhexidine, a disinfectant often used in hospitals, compared to other sporadic KPC-producing clones, suggesting its possible selective advantage in the hospital environment (Naparstek et al. 2012) .
The capsule diversity was mentioned as another possible unique feature of CG258; Wyres et al. performed an in silico analysis based on 39 available WGS data (26-ST258, 9-ST11 and 4-other STs), identified 11 distinct capsule variants in this CG.
Klebsiella pneumoniae ST11, the progenitor of CG258, was found to comprise seven cps locus types compared to one or two loci in other STs. It was suggested that this diverse capsule content may complicate the recognition of this CG by the immune system and explain the high occurrence of these STs (Wyres et al. 2015) . Based on the evolutionary study that showed that two recombination events occurred in cps loci during the evolvement of ST258 (Chen et al. 2014c; Deleo et al. 2014) , the cps region of K. pneumoniae was recognized as a 'hot spot' for genetic rearrangements and for chromosomal homologous recombination events. These may reflect the genetic flexibility of K. pneumoniae and possibly the route of emergence of HiR clones.
CG258 pitfalls
Contradictory data in the literature demonstrate weak physiological traits of CG258. A fitness study comparing ST512, a CG258 high-prevalent outbreak clone with ST321, a sporadic clone, showed, unexpectedly, the superiority of the later in growth competition experiments (Benenson et al. 2012) . This in vitro study demonstrates the fitness enigma and presents the need of further understanding the relation between fitness of clones, epidemicity and host-related factors. Increased virulence of CG258 lineages is also far from being proved. ST258 isolates show variable virulence potential in several animal models (Pitout, Nordmann and Poirel 2015) . In a study from Greece, ST258 isolates showed low virulence in a mouse model of septicemia, easily removable by the immune system in vitro, and shown to contain a non-virulent capsule type (Tzouvelekis et al. 2013) . In another study, based on WGS of only three isolates, each belonging to a different ST, the numbers of virulence genes found in K. pneumoniae ST11 and ST512 were lower compared to those found in the high-risk clone ST101 (Oteo et al. 2016) . With respect to biofilm formation, K. pneumoniae ST258 showed low biofilm production in vitro compared to non-ST258 sporadic clones (Naparstek et al. 2014) , which was further supported by a transcriptome analysis (Bruchmann et al. 2015) .
The success of non-CG258 clones
Understanding the successful dissemination of other (non-CG258) HiR clonal groups has yet to be studied. The importance of having a XDR phenotype together with the presence of certain MGEs was suggested. High-risk ST14, ST147, ST37 and ST101 tend to be armed with carbapenemases, whereas ST15 and ST17 are mostly ESBL-carrying clones; almost 40% of isolates belonging to each of these two high-risk clones are CTX-M producers (Table 2) . A study from Taiwan on epidemic ESBL and AmpCproducing K. pneumoniae clones found that the high-risk clones ST11, ST15, ST147 and ST37 all share the same ompK36 allele, group A, suggesting their convergent evolution, but the actual role of this porin allele in their success has not been further elucidated (Yan et al. 2015) .
Contribution of plasmids to HiR clones success
The contribution of K. pneumoniae conjugable plasmids to the success of HiR clones was discussed in the context of coresistance to multiple classes of antibiotics. The HiR ST258 emerged in early 2000s with the pKpQIL and pKpN3 plasmids, but these plasmids have been also identified in more recently isolated strains within CG258, suggesting that they are conserved and maintained stably within the clone (Leavitt et al. 2010; Chen et al. 2014a) . pKpQIL contributed to the epidemiological success of the clone, conferring carbapenem resistance, but pKPN3 also could play a role in adaptation and fitness of CG258 because it was conserved in the majority of the isolates. Along the years, pKPN3 evolved more than pKpQIL acquiring different determinants, including the carbapenem resistance and novel putative virulence genes. The discrimination in clades I and II of the CG258 corresponded to a discrimination of the plasmid content which resulted different in the two separated clades, thanks to the acquisition of an IncI2 by clade II (Chen et al. 2013a; Deleo et al., 2014) . However, the virulence properties of these IncFIIk plasmids have not been formally demonstrated. A recent review by Lee et al. describes two examples of bacterial success related to plasmid carriage. The first is bla NDM -encoding plasmids, especially IncA/C, which often harbor aminoglycoside and fluoroquinolone resistance genes that can contribute to their selection and spread among K. pneumoniae. A second example is IncL plasmids encoding bla OXA-48 , (Table 1) ; their high conjugation rate may lead to wide distribution with further selection under antibiotic pressure (Lee et al. 2016) . Studies on the superiority of these HiR clones among other K. pneumoniae STs are lacking and should be further elucidated in order to eliminate or at least control their efficient spread.
Routes of global dissemination of HiR CRKP clones
XDR CRKP HiR clones have been spreading around us for nearly two decades, posing a great threat due to limited treatment options and increased mortality (Doi and Paterson 2015; Campos et al. 2016) . All nine HiR clones show worldwide spread in three to five continents (Table 2) . Spread of these clones is a complex process that includes local, national and international events. Although transmission routes may be enigmatic, the literature highlights numerous routes of transmission presented schematically in Fig. 4 . Transmission modes may involve in-hospital patient-to-patient spread, acquisition following contacts with positive colonizers, as well as transmission via medical travel, and possibly through the food chain, companion animals and environmental sources (Fig. 4) .
Medical-associated spread
Risk factors for acquisition of K. pneumoniae infection concern medical treatment and healthcare facilities, i.e. recent antibiotic use, catheter carriage and prolonged hospitalization (Boyle and Zembower 2015) . Therefore, K. pneumoniae is recognized as a typical and even dominant nosocomial pathogen (Pitout, Nordmann and Poirel 2015) . In hospitals, K. pneumoniae spreads from person to person. Interestingly, the ability to spread CRKP varies between different carriers: only few of them, probably those with higher rectal K. pneumoniae concentration, are significantly responsible for environmental contamination (Lerner et al. 2015) . Colonization may last up to 2-4 years (Conlan et al. 2016) . Carriers of K. pneumoniae do not always develop disease.
The ability of K. pneumoniae to survive on hospital equipment surfaces facilitates K. pneumoniae distribution. A ventilatorassociated outbreak in China is a dramatic example of successful transmission of KPC-2 ST11 K. pneumoniae bypassing patient-to-patient contact (Hu et al. 2016) . Dissemination of K. pneumoniae ST278 isolated from different patients in the same hospital unit in Calgary demonstrated rapid changes within resistance regions pointing out the high genetic plasticity of this bacterium (Lynch et al. 2016) . Thus, the most sufficient measures during ongoing outbreak are active surveillance and strict K. pneumoniae carrier isolation, including spatial segregation and division of staff into one group caring for infected or colonized patients and the other working with non-carriers only (Schwaber and Carmeli 2014) . In Italy, an outbreak in a neonatal intensive care unit was successfully prevented by an active surveillance program when all carriers were detected and treated with antibiotic combination before development of acute infection (Giuffrè et al. 2013) . Early recognition of positive colonization by active surveillance was found as the most effective measure against KPC-producing K. pneumoniae (Campos et al. 2016) .
Long-term care facilities (LTCFs) are hypothesized to be a connecting link in the spread of MDR Enterobacteriaceae between the hospital and the community settings (Endimiani et al. 2009 ). Additional reports supported the importance of LTCF as a reservoir for CRKP (Adler, Katz and Marchaim 2016) . LTCFs can even be sources of reintroduction of bacteria into hospitals and implementation of prevention measures is much more complicated in these wards (Schwaber and Carmeli 2014) .
Spread of CRKP in the community setting is still scarce. The first report described transfer of a hospital-acquired CRKP after discharge to a family member (Gottesman et al. 2008) . Additional cases included complicated cystitis in an old woman with NDM-producing K. pneumoniae , and a case of urinary tract infection caused by KPC-producing K. pneumoniae ST258 in a young pregnant woman without recent health care exposures or travel history (Khatri et al. 2015) . These few reports highlight the potential emergence of CRKP in community-associated infections and echoes the uncontrolled ESBL-producing K. pneumoniae situation in the community.
Animal reservoir of CRKP
Possible reservoirs for circulating CRKP clones are animals that can exchange pathogens with humans via the food chain, close contact or occupational transmission. High-risk human CR K. pneumoniae STs were reported in various companion animals in the community: for example, K. pneumoniae ST15 carrying bla in dogs from a veterinary clinic in Germany (Stolle et al. 2013) , and different animals from Japan, France, Germany and other European countries infected and colonized with bla CTX-M-15 carrying clones Ewers et al. 2014; Harada et al. 2016) . Klebsiella pneumoniae ST11-producing DHA-1 was associated with morbidity of wild animals in Europe (Pilo et al. 2015; Loncaric et al. 2016) . The role of animals as a reservoir for HiR CRKP clones and its impact on human health still remains unclear and should be further explored.
International spread
Global spread of HiR clones can occur due to international travel and tourism (Van der Bij and Pitout 2012) . This may include medical travel (Rogers et al. 2011) , during trips in which people are occasionally in contact with healthcare facilities, or visiting an endemic country. The first case of bla KPC-3 encoding ST258 outside the USA was reported in Israel (Navon-Venezia et al. 2009 ). Patients can be transferred from epidemic regions and spread a novel pathogen as it was shown for bla OXA-48 -carrying K. pneumoniae ST101 isolated from foreign patients in Israel (Adler et al. 2011) ; or a patient can be subjected to infection during hospitalization in an endemic country, as with VIM-27-producing K. pneumoniae ST147 which moved from Greece to Luxembourg (Bogaerts et al. 2011) . Acquisition of various HiR clones bla NDM-1 -and bla KPC-2/3 -producing CRKP was reported in Canadian travelers who returned from different countries, and needed further hospitalization (Peirano et al. 2014) . Active surveillance of returning patients hospitalized in endemic areas and infection control actions are recommended to eliminate further spread to avoid new acquisitions. Transfer of ESBL-producing HiR clones may be linked to the food chain and international trade relations like consumption of various vegetables in Switzerland carrying bla CTX-M -encoding ST15 and ST37, and bla SHV -encoding ST17 and ST147, acquired from endemic countries (Zurfluh et al. 2015) . The global spread of KPC-carrying K. pneumoniae and NDM-1-producing Enterobacteriaceae was summarized by Molton et al. (2013) , without indicating the STs involved.
Thus, fast dissemination of K. pneumoniae clones and resistance genes is a serious threat requiring immediate actions. Active surveillance must be introduced in all healthcare facilities; measures for arresting environmental contamination should be developed and become routinely used. Further studies are warranted for understanding the secret of success of high-risk clones and their transmission. This could be further elucidated using RNA-seq approach to identify differentially expressed genes with clinically relevant phenotypes for specific high-risk clones, and to understand the conditions that facilitate their spread. Identification of unique markers for specific highrisk clones will assist in effective screening of carriers, control transmission by rational cohorting and improve diagnostics.
CONCLUSIONS
Klebsiella pneumoniae plays a major role in the worldwide burden of antibiotic resistance. This burden is mainly hospitalassociated, and involves HiR epidemic strains that possess a super resistome and cause infections with limited treatment options, leading to increased complications, higher mortality rates and costs.
Being a hospital-associated pathogen, Klebsiella is continuously exposed to multiple antibiotics resulting in constant selective pressure, which in turn leads to additional mutations that are positively selected. We showed that the resistome of K. pneumoniae encompasses a wide array of ARGs that continuously evolve and diversify (Fig. 2) . Although various K. pneumoniae isolates may differ in their resistome repertoire, depending on geographic location, cultural population exchange, antibiotic stewardship and possible resistant reservoirs, this species shows a flexible ability to accumulate and switch resistances. Interestingly, ARGs that encompass the resistome can be located on the bacterial chromosome or on plasmids. Within a single genome, chromosomally encoded AR elements can move onto plasmids and vice versa. Plasmid-mediated resistome and transposons can also transfer and disseminate horizontally to other K. pneumoniae strains and occasionally to other bacterial species.
Plasmids are present in almost all K. pneumoniae strains, and the replicon content in this species very often diverges from other Enterobacteriaceae species replicons. Plasmid analysis highlights the impressive diversity of replicon types associated with the same carbapenemase or ESBL gene. Among them, broad host range, successful plasmids of the IncX3, IncA/C, IncN and IncL groups often associated with the bla NDM , bla OXA-48 and bla CTX-M genes. Klebsiella pneumoniae acquired these epidemic plasmids and then often acts as the harbinger of resistance determinants among other enterobacteria.
However, the most frequent plasmids in K. pneumoniae are the narrow host range IncFIIk plasmids, associated with the KPC carbapenemase. These plasmids and bla KPC are highly specific for Klebsiella genomes and are characteristics of the K. pneumoniae species. Numerous open reading frames encoding proteins with unknown function have been annotated on the K. pneumoniae plasmids and are very often unique, not being present in other bacterial genomes, and likely deriving from HGT from undefined species. These gaps of knowledge in the attribution of functions to plasmids have left open the possibility that they contribute significantly to the success of this species not only as vehicles of resistance genes.
We described nine HiR worldwide MDR and XDR K. pneumoniae STs associated with multicontinent outbreaks. These clones possess a wide diversity of bla gene content, diverse resistomes and multiple plasmid types, supporting the complex epidemiology involved in multiresistant Klebsiella; this indicates an ability to acquire locally prevalent ARGs, and ARG-encoding plasmids, together with direct dissemination of a particular clone combined with a specific resistome, as well as a continuous influx of strains due to globalization and silent reservoirs. Taking into account these dynamic processes and the severe outcome related to infections caused by these clones, there is a need for an accurate molecular typing of both clones and genes. With the reduction in cost, and availability of MLST and WGS, we presume these methods will become more and more available for diagnosis of infectious diseases, both in patients and carriers. There are numerous examples in the literature showing that active surveillance to identify positive CREs colonizers is highly effective to control spread. We highlight the importance of molecular identification of specific HiR clones which may be crucial for applying the suitable infection control actions to avoid spread. Figure 4 summarizes the hallmarks of the emergence and spread of MDR and XDR Klebsiella clones and mentions the routes of global dissemination of this pathogen. We propose that the key for the success of K. pneumoniae as a pioneer and spreader of antibiotic resistance is directly related to the fact that this pathogen is sited in, and highly fitted to hospitals. It is interesting to note that it is enteric counterpart, carbapenem-resistant E. coli, which has been known to acquire plasmid-mediated carbapenemases, has not become epidemic. The prevalence of carbapenem-resistant E. coli is still very low compared to CRKP (Fig. 1) , even in countries in which it has been introduced, carbapenem-resistant E. coli clones are not spreading successfully. We can speculate that the epidemic traits of HiR Klebsiella clones involve plasmid-strain combination and need further understanding.
In conclusion, while past reports described that the type of CRE depends on the country, and might be associated with historical and or cultural relations and exchange of populations with high-prevalent countries (Cantón et al. 2012) , it is now clear that globalization plays an important role in the dissemination of CRKP. Countries that were considered as endemic for only one type of carbapenemase such as KPC-producing K. pneumoniae/ST258 in Israel and VIM-producing K. pneumoniae in Greece, now deal with numerous carbapenemases and even multiple clones (Mathers, Peirano and Pitout 2015; Pitout, Nordmann and Poirel 2015) .
The vast information and knowledge retrieved from whole genome DNA sequencing data of HiR clones and MGEs drives the need to deepen our understanding of functional resistance, including conditions that affect the expression of the resistome, as well as to define the mechanisms involved in these expression patterns. It is therefore crucial to understand the role of antibiotics on regulation of ARG expression and on their rate of dissemination. Future genomic and translational studies should be designed to decipher the secrets of success and adaptation of Klebsiella HiR clones.
Multiple efforts for tracking XDR Klebsiella using active surveillance for identifying gastrointestinal carriage in local (Forcina et al. 2016 ) and nation-wide levels have been undertaken, and are reported as highly successful in limiting the spread and decreasing the number of new acquisitions (Metan and Akova 2016) . In spite of these efforts, resistance rates have increased both in Klebsiella and in other human-affecting pathogens, giving rise to concerns about the importance of additional reservoirs.
